Small Cell Carcinoma

Oncology·MeSH: Carcinoma, Small Cell

Prevalence

0.1 / 100K

37 drugs in development·9 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(17)

Drug	Company
capmatinib	GH Research PLC (GHRS)
Cemiplimab	ENANTA PHARMACEUTICALS INC (ENTA)
Ceralasertib	ENANTA PHARMACEUTICALS INC (ENTA)
Ceralasertib	Crinetics Pharmaceuticals, Inc. (CRNX)
Cetuximab Sarotalocan Sodium	FATE THERAPEUTICS INC (FATE)
Ensartinib	ENANTA PHARMACEUTICALS INC (ENTA)
Ensartinib	Merus N.V. (MRUS)
Erlotinib	Amneal Pharmaceuticals, Inc. (AMRX)
Erlotinib Hydrochloride	Amneal Pharmaceuticals, Inc. (AMRX)
Etoposide	ADMA BIOLOGICS, INC. (ADMA)
Immune Checkpoint Inhibitor	Merus N.V. (MRUS)
Immune induction therapy	Merus N.V. (MRUS)
osimertinib	GH Research PLC (GHRS)
Osimertinib	Amneal Pharmaceuticals, Inc. (AMRX)
Pemetrexed Disodium	ADMA BIOLOGICS, INC. (ADMA)
ramucirumab	GH Research PLC (GHRS)
tepotinib	GH Research PLC (GHRS)

Phase 2(10)

Drug	Company
Cemiplimab	Assertio Holdings, Inc. (ASRT)
Cemiplimab	FATE THERAPEUTICS INC (FATE)
ceralasertib	GH Research PLC (GHRS)
Crizotinib	Amneal Pharmaceuticals, Inc. (AMRX)
Diclofenac Potassium	ENANTA PHARMACEUTICALS INC (ENTA)
Ensartinib	ADMA BIOLOGICS, INC. (ADMA)
Lurbinectedin	Jazz Pharmaceuticals plc (JAZZ)
Pemetrexed	Amneal Pharmaceuticals, Inc. (AMRX)
platinum compound	GH Research PLC (GHRS)
saruparib	GH Research PLC (GHRS)

Phase 1(3)

Drug	Company
Crizotinib	ENANTA PHARMACEUTICALS INC (ENTA)
Iadademstat	ENANTA PHARMACEUTICALS INC (ENTA)
Pemetrexed	ADMA BIOLOGICS, INC. (ADMA)

N/A(4)

Drug	Company
Crizotinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Erlotinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Pemetrexed Disodium	Crinetics Pharmaceuticals, Inc. (CRNX)
Pemetrexed Disodium	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 2/Phase 3(1)

Drug	Company
nogapendekin alfa	GH Research PLC (GHRS)

Phase 4(2)

Drug	Company
Diclofenac Potassium	Assertio Holdings, Inc. (ASRT)
monalizumab	GH Research PLC (GHRS)

BioSniper tracks 37 drugs in development for Small Cell Carcinoma across 9 companies.

There are 2 clinical trials targeting Small Cell Carcinoma tracked by BioSniper.

The estimated prevalence of Small Cell Carcinoma is approximately 0.1 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.